Advances in targeted therapies V: Proceedings of the 5th International Symposium. St Martin, French West Indies. 11-14 April 2003.
作者信息
Breedveld F, Kalden J, Smolen J
出版信息
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii1-96. doi: 10.1136/ard.62.suppl_2.ii1.
Abstract
摘要
相似文献
1
Advances in targeted therapies V: Proceedings of the 5th International Symposium. St Martin, French West Indies. 11-14 April 2003.靶向治疗进展V：第五届国际研讨会会议记录。法属西印度群岛圣马丁。2003年4月11日至14日。
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii1-96. doi: 10.1136/ard.62.suppl_2.ii1.
2
Safety and efficacy of the biologic response modifiers.生物反应调节剂的安全性和有效性。
Am J Orthop (Belle Mead NJ). 2007 Mar;36(3 Suppl):15-9.
3
Updated consensus statement on biological agents for the treatment of rheumatoid arthritis and other immune mediated inflammatory diseases (May 2003).关于治疗类风湿关节炎及其他免疫介导的炎性疾病的生物制剂的更新共识声明（2003年5月）
Ann Rheum Dis. 2003 Nov;62 Suppl 2(Suppl 2):ii2-9. doi: 10.1136/ard.62.suppl_2.ii2.
4
Proposed guidelines for the clinical evaluation of interleukin-1 inhibitors in the treatment of rheumatoid arthritis.白细胞介素-1抑制剂治疗类风湿关节炎的临床评估拟议指南。
Eur Cytokine Netw. 1990 Oct-Nov;1(4):235-7.
5
[Biopharmaceuticals in the treatment of rheumatoid arthritis].[生物制药在类风湿关节炎治疗中的应用]
Ugeskr Laeger. 2008 Jun 9;170(24):2108-10.
6
Treatment of inflammatory immunologic disease 3. Anti-TNF therapy in rheumatoid arthritis.炎症性免疫疾病的治疗3. 类风湿关节炎中的抗TNF治疗。
Intern Med. 2007;46(16):1311-2. doi: 10.2169/internalmedicine.46.1913. Epub 2007 Aug 15.
7
Rheumatoid arthritis therapy after tumor necrosis factor and interleukin-1 blockade.
Arthritis Rheum. 2003 Dec;48(12):3308-19. doi: 10.1002/art.11358.
8
Cytokines in rheumatoid arthritis: trials and tribulations.类风湿关节炎中的细胞因子：试验与磨难
Mol Med Today. 2000 Aug;6(8):315-23. doi: 10.1016/s1357-4310(00)01757-3.
9
Rheumatoid arthritis.类风湿关节炎
Am J Nurs. 2000 Nov;100(11):40-3.
10
[Off-label use of biological therapies in systemic diseases].[生物疗法在全身性疾病中的非适应证使用]
Rev Med Interne. 2010 Dec;31 Suppl 3:S307-14. doi: 10.1016/j.revmed.2010.09.015. Epub 2010 Oct 30.
Zotero 插件